000			01562 a2200397 4500
005			20250516134737.0
264		0	_c20140130
008			201401s 0 0 eng d
022			_a1000-467X
024	7		_a10.5732/cjc.012.10319 _2doi
040			_aNLM _beng _cNLM
100	1		_aStacker, Steven A
245	0	0	_aThe VEGF signaling pathway in cancer: the road ahead. _h[electronic resource]
260			_bChinese journal of cancer _cJun 2013
300			_a297-302 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aHumans
650	0	4	_aLymphangiogenesis
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNeovascularization, Pathologic _xmetabolism
650	0	4	_aPlacenta Growth Factor
650	0	4	_aPregnancy Proteins _xmetabolism
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aVascular Endothelial Growth Factor A _xclassification
650	0	4	_aVascular Endothelial Growth Factor B _xmetabolism
650	0	4	_aVascular Endothelial Growth Factor C _xmetabolism
650	0	4	_aVascular Endothelial Growth Factor D _xmetabolism
700	1		_aAchen, Marc G
773	0		_tChinese journal of cancer _gvol. 32 _gno. 6 _gp. 297-302
856	4	0	_uhttps://doi.org/10.5732/cjc.012.10319 _zAvailable from publisher's website
999			_c22513728 _d22513728